There is provided combination products comprising (a) ramatroban, or a
pharmaceutically-acceptable salt or solvate thereof and (b) a statin, or
a pharmaceutically-acceptable salt or solvate thereof. Such combination
products find particular utility in the treatment of atherosclerosis and
related conditions.